https://www.selleckchem.com/pr....oducts/trastuzumab-d
ate our findings and assess their prognostic significance. Depression is common in patients with acute cardiovascular conditions and it is associated with adverse clinical events. Using the data from a nationwide, prospective registry on patients with chronic coronary syndromes (CCS), we assessed the impact of depression on major adverse cardiovascular events (MACE), a composite of all-cause death and hospitalization for myocardial infarction, revascularization, heart failure or stroke, and quality of life (QoL) at 1-year